Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Kristian Munck

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Gut|July 24, 2013
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trialCasper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
International Journal of Colorectal Disease|September 13, 2020
Distribution of histopathological features along the colon in microscopic colitisAnne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
The Lancet. Gastroenterology & Hepatology|February 9, 2023
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trialChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2021
Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long-term prognosisLaerke Müller Olsen, Peter Johan Heiberg Engel, Danny Goudkade, et al.
The American Journal of Gastroenterology|August 3, 2020
Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid TestChristian Borup, Signe Wildt, Jüri Rumessen, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2023
Prospective comparison of diagnostic tests for bile acid diarrhoeaChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Gut|July 24, 2013
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trialCasper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, et al.
Journal of Crohn'S & Colitis|September 25, 2021
The Process of Developing a Disease Activity Index in Microscopic ColitisKatarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, et al.
International Journal of Colorectal Disease|September 13, 2020
Distribution of histopathological features along the colon in microscopic colitisAnne-Marie Kanstrup Fiehn, Stephan Miehlke, Daniela Aust, et al.
The Lancet. Gastroenterology & Hepatology|February 9, 2023
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trialChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2021
Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long-term prognosisLaerke Müller Olsen, Peter Johan Heiberg Engel, Danny Goudkade, et al.
The American Journal of Gastroenterology|August 3, 2020
Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid TestChristian Borup, Signe Wildt, Jüri Rumessen, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2023
Prospective comparison of diagnostic tests for bile acid diarrhoeaChristian Borup, Lars Vinter-Jensen, Søren Peter German Jørgensen, et al.
Pageof 4